[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth

Detalles Bibliográficos
Autores principales: Xuan, Zi-Xue, Li, Lin-Na, Zhang, Qi, Xu, Cheng-Wang, Yang, De-Xuan, Yuan, Ye, An, Ying-Hong, Wang, Shan-Shan, Li, Xiao-Wen, Yuan, Shou-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631764/
https://www.ncbi.nlm.nih.gov/pubmed/37888731
http://dx.doi.org/10.3892/ijo.2023.5583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631764/
https://www.ncbi.nlm.nih.gov/pubmed/37888731
http://dx.doi.org/10.3892/ijo.2023.5583

Ejemplares similares